Eyenovia Future Growth
Future criteria checks 2/6
Eyenovia is forecast to grow earnings and revenue by 28.9% and 54.4% per annum respectively while EPS is expected to grow by 31.1% per annum.
Key information
28.9%
Earnings growth rate
31.1%
EPS growth rate
| Pharmaceuticals earnings growth | 21.1% |
| Revenue growth rate | 54.4% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 08 Apr 2024 |
Recent future growth updates
Recent updates
Is Eyenovia (NASDAQ:EYEN) Weighed On By Its Debt Load?
Jan 30
Is Eyenovia (NASDAQ:EYEN) Using Debt In A Risky Way?
Oct 14Is Eyenovia (NASDAQ:EYEN) Using Debt Sensibly?
Jun 27Does Eyenovia (NASDAQ:EYEN) Have A Healthy Balance Sheet?
Oct 25Eyenovia gains as H.C. Wainwright initiates with Buy on pipeline potential
Oct 05Eyenovia names Michael Rowe as new CEO
Jul 27New Forecasts: Here's What One Analyst Thinks The Future Holds For Eyenovia, Inc. (NASDAQ:EYEN)
Apr 03Earnings Beat: Eyenovia, Inc. (NASDAQ:EYEN) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Mar 31Eyenovia: I Can See You Better - Now
Mar 04Eyenovia: Reassessing After The FDA Moves The Goalposts
Nov 23Eyenovia: FDA Setback Is Big Opportunity For Investors
Nov 08Eyenovia: Can You See Me Now?
Oct 21Is Eyenovia (NASDAQ:EYEN) A Risky Investment?
Sep 16Eyenovia updates on late-stage program for presbyopia therapy
Jun 15Eyenovia: Recent MicroLine Data, October MydCombi PDUFA Date Bode Well For Value Creation
Jun 02Eyenovia announces new $25M credit facility with Silicon Valley Bank
May 10Stuart Grant Just Bought A Sprinkling of Shares In Eyenovia, Inc. (NASDAQ:EYEN)
Mar 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 35 | -25 | -20 | N/A | 2 |
| 12/31/2025 | 12 | -42 | -36 | N/A | 4 |
| 12/31/2024 | 5 | -32 | -39 | -34 | 3 |
| 12/31/2023 | 0 | -27 | -28 | -24 | N/A |
| 9/30/2023 | 0 | -25 | -27 | -23 | N/A |
| 6/30/2023 | N/A | -25 | -26 | -24 | N/A |
| 3/31/2023 | N/A | -26 | -25 | -24 | N/A |
| 12/31/2022 | N/A | -28 | -26 | -25 | N/A |
| 9/30/2022 | 10 | -19 | -27 | -26 | N/A |
| 6/30/2022 | 10 | -17 | -25 | -24 | N/A |
| 3/31/2022 | 12 | -15 | -26 | -24 | N/A |
| 12/31/2021 | 14 | -13 | -22 | -21 | N/A |
| 9/30/2021 | 6 | -20 | -11 | -10 | N/A |
| 6/30/2021 | 6 | -19 | -7 | -6 | N/A |
| 3/31/2021 | 4 | -20 | -6 | -5 | N/A |
| 12/31/2020 | 2 | -20 | -7 | -6 | N/A |
| 9/30/2020 | N/A | -21 | -16 | -16 | N/A |
| 6/30/2020 | N/A | -20 | -18 | -18 | N/A |
| 3/31/2020 | N/A | -21 | -19 | -19 | N/A |
| 12/31/2019 | N/A | -21 | -19 | -19 | N/A |
| 9/30/2019 | N/A | -22 | -19 | -19 | N/A |
| 6/30/2019 | N/A | -22 | -19 | -19 | N/A |
| 3/31/2019 | N/A | -20 | -17 | -17 | N/A |
| 12/31/2018 | N/A | -17 | -13 | -13 | N/A |
| 9/30/2018 | N/A | -13 | -11 | -11 | N/A |
| 6/30/2018 | N/A | -10 | -8 | -8 | N/A |
| 3/31/2018 | N/A | -7 | -6 | -6 | N/A |
| 12/31/2017 | N/A | -5 | -5 | -5 | N/A |
| 9/30/2017 | N/A | -4 | N/A | -4 | N/A |
| 12/31/2016 | N/A | -4 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EYEN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: EYEN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: EYEN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: EYEN's revenue (54.4% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: EYEN's revenue (54.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EYEN's Return on Equity is forecast to be high in 3 years time